cytarabine has been researched along with isatin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Annageldiyev, C; Bhattacharya, P; Claxton, D; Desai, D; Dovat, S; Feith, DJ; Gowda, K; Iyer, S; Loughran, TP; Patel, T; Sharma, A; Tan, SF | 1 |
1 other study(ies) available for cytarabine and isatin
| Article | Year |
|---|---|
The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia.
Topics: Animals; Antigens, CD34; Cytarabine; Interleukin-3 Receptor alpha Subunit; Isatin; Leukemia, Myeloid, Acute; Mice; Neoplastic Stem Cells; Nucleophosmin | 2020 |